Summary.-Lewis lung carcinoma cells were implanted in the foot-pads of mice and the effects of the plasminogen-plasmin inhibitor tranexamic acid (t-AMCHA) and of the plasminogen activator urokinase on metastasis were examined by electron microscopy. The intravascular tumour cells were not associated with thrombus formation in either control or urokinase -treated mice. Polymerized fibrin deposition around tumour cells and thrombi composed of fibrin and platelets was observed only in the mice given t-AMCHA. This suggests that the inhibition of fibrinolysis by tACC caused fibrin deposition and thrombus formation around intravascular tumour cells, which prevented release of the cells from primary foci to form secondary tumours. On the other hand, fibrinolysis induced by urokinase prevented thrombus formation, and accelerated cell release from primary foci.
HAEMATOGENOUS METASTASIS is a continuous process consisting of several stages: (i) growth of primary tumours, (ii) invasion of tumour cells into the vessels, (iii) release and circulation of tumour cells and (iv) lodgement and secondary growth in distant organs. Several reports (Peterson, 1968; Tanaka et al., 1977; Clark, 1979; Donati et al., 1978) have suggested that the coagulation-fibrinolysis system plays different roles in the various stages of metastasis. Some workers (Jones et al., 1971; Warren & Vales, 1972; Chew & Wallace, 1976; Kinjo, 1978) have demonstrated the association of fibrin with tumour-cell emboli in distant organs. Fibrin formation may aid in tumour arrest and adherence to blood vessel endothelium. On the other hand, tumour-cell release from primary foci is prior to cell lodgement in the destination organs. However, tumour-cell-fibrin interaction in this stage is still unclear for lack of adequate models. The previous study showed that the plasminogen-plasmin inhibitor trans-4-aminomethyl cyclohexane-1 -carboxylic acid (t-AMCHA, tranexamic acid) decreased, and the plasminogen activator urokinase increased, the number of pulmonary metastases of Lewis lung carcinoma. These effects were considered to be mediated by the prevention and enhancement of cell release, due to t-AMCHA and urokinase, respectively.
The purpose of the present study is to clarify the effects of t-AMCHA and urokinase on the metastasis of Lewis lung carcinoma. Tumour-cell invasion sites were examined electron-microscopically, with special reference to tumour-cell-fibrin interaction.
MATERIALS AND METHODS
Tranexamic acid (trans-4-aminomethyl cyclohexane-1 -carboxylic acid) (Transamin, Daiichi Seiyaku Co. Ltd, Tokyo, Japan, t-AMCHA) and urokinase (Uronase, Mochida Pharmaceutical Co. Ltd, Tokyo, Japan, UK) were used.
The experimental procedure has previously been described . Lewis lung carcinoma was passaged in male C57BL/6 mice (Charles River Japan Inc., Atsugi, Japan). The gently homogenized cells wvere filtered using 150 platinum mesh and suspended in Hanks' balanced salt solution at the rate of 106/ml, and 0-1 ml of the suspension was inoculated into the foot pads of 10 female BDFI mice (C57BL/6 x DBA/2) in each group: the viability of the tumour cells w-as 30%O according to the trypan-blue test.
The tumour-bearing legs were amputated 12 days after inoculation and the mice were necropsied 23 days after transplantation. Administrations of urokinase and t-AMCHA wA-ere begun 1 day before inoculation and continued until the day of amputation: twicedaily i.v. injections of urokinase at a dosage of 10,000 u/kg, and oral administration of t-AMCHA in the food, equivalent to a dose of 3 g/kg a day. Untreated On Day 23, animals were examined for the development of metastases. The numbers of metastatic foci on the pleural surfaces of both lungs were counted with the naked eye.
The data wsere statistically analysed by Krusskall-Wlallis test.
RESULTS
The mean numbers of pulmonary metastatic foci of 10 mice were 21-2 + 25 44-1 + 2-3, and 7 0 + 1P9 (mean + s.e.) in the control, urokinase-and t-AMCHAtreated groups of mice respectively. Urokinase increased the number of metastatic foci (P < 0.05). On the other hand, in the mice given t-AMCHA, the number of metastatic foci was significantly lower than in the untreated (P < 0.05). Invasion of tumour cells into the vascular lumina was observed in the primary foci excised from the mice on the 12th day. Free tumour cells were frequent in the sinusoidal vessels but rare in the veins. Out of 30 vessels of each of 5 animals, the incidences of these with free tumour cells were 29, 40 and 20% in control, urokinaseand t-AMCHA-treated mice respectively. The highest incidence in the urokinasetreated group coincided with the largest number of metastatic foci in the lungs of this group. Thrombus formation associated with intravasated tumour cells was rare in the control (13.700 of the vessels containing tumour cells) and absent in the urokinase-treated animals, but frequent in the t-AMCHA-treated mice (450 of such vessels) (Table) . In the tumours of the control mice, capillary endothelial cells were torn apart at the sites of invasion and tumour cells invaded the capillary. lumina without thrombus formation or fibrin deposition (Fig. 1) . Although a small amount of fibrin formation was occasionally seen at the invasion sites (Fig. 2) , fixed thrombus formation was not seen with electron microscopy in the control mice. However, in the mice treated with t-AMCHA, few tumour cells were seen in the vessels of the primary foci, and the intravascular tumour cells were often associated with thrombi (Fig. 3) . These thrombi were mainly composed of platelets and polymerized fibrin identified by immunofluorescence tests using anti-mousefibrinogen serum (Fig. 4) (Fig. 7) . Amorphous faintly positive fluorescence for fibrinogen was seen around the cells (Fig. 8) , though no polymerized fibrin deposition was seen ultrastructurally (Fig. 9) .
DISCUSSION
The inhibitory effect of t-AMCHA on spontaneous metastasis have been demonstrated by Peterson (1968) with mouse mammary carcinoma, and by Kodama & Tonaka (1981) with rabbit V2 carcinoma. Kodama & Tonaka (1978) also showed that the administration of urokinase accelerated the metastasis of rabbit V2 carcinoma. We also previously reported that t-AMCHA decreased the number of pulmonary metastases of Lewis lung carcinoma implanted into the foot pads, but, on the other hand, urokinase increased the number of the metastases in the mice . The use of t-AMCHA and urokinase can be expected to clarify the role of fibrin in metastasis, because t-AMCHA is an inhibitor of the activation of plasminogen, but slightly inhibits the esterolytic and caseinolytic activities of plasmin (Iwamoto et al., 1968 (Iwamoto et al., , 1975 Abiko et al., 1969) -in other words, t-AMCHA inhibits highly specifically the fibrinolytic activity of plasmin, while urokinase is an activator of plasminogen. In the previous study , light microscopy showed that, in mice treated with t-AMCHA, the tumour cells in the vessels of primary foci were often associated with thrombi. Light microscopy, however, cannot resolve the fine details of the tumour-cell-fibrin interaction. Immunofluorescence studies gave AMCHA. This periodic pattern is characteristic of the structure of polymerized fibrin (Hawn & Porter, 1947; Kay & Cuddingan, 1967) . Tumour cells invaded the blood vessels via the site of breaching of the endothelial cells. Although a small amount of fibrin deposition was seen at the invasion site in the control mice, the invading cells were not associated with thrombus formation in control and urokinase-treated mice. This suggests that no thrombus formation was due to the fibrinolytic activity of plasmin, which can rapidly convert a small amount of fibrin to FDPs at the invasion sites. Polymerized stable fibrin deposition around tumour cells, and thrombi composed of fibrin and platelets were characteristic findings in mice under t-AMCHA administration, which does not participate in the process of thrombus formation at all, in spite of its antifibrinolytic action (Tomikawa, 1975) . This indicates that the fibrinolytic activity of Lewis lung carcinoma cell alone, and/or that of host animals induced by fibrin deposition, might be inhibited by t-AMCHA. Lewis lung carcinoma has been shown by Kohga et al. (1981) to have relatively low fibrinolytic activity; therefore inhibition of fibrin resolution induced by continuous administration of t-AMCHA could finally cause formation of thrombi visible in light microscopy, and consequently, these thrombi, associated with tumour cells, prevented cell detachment and cell release, forming secondary metastasis from primary foci.
